Scott Conry

Background

About Scott Conry

I have spent the past 20 years in a variety of roles in the health care industry including 15 plus years in the pharmaceutical industry. My skills as a dynamic and influential presenter and leader have served me well in positions of increasing responsibility ranging from medical liaison to multiple director roles in medical training, field medial affairs, and clinical educator teams. My varied skill set has served me well in leading field based medical teams responsible for KOL development and strategic product and medical education. Key accomplishments include being the training lead for the launch of the Oncology business unit at Sanofi for Eloxatin, Elitek, and Eligard. Eloxatin was the first oncology product to achieve greater than $1 billion dollars in sales its first year on the market. I have supported clinical research and development and led the inaugural clinical educator team in North America for a phase antiplatelet medication at Schering-Plough. Our team increased patient enrollment and shortened phase completion by eight months. I have participated in a variety of strategic medical affairs roles including working with global medical directors on investigator initiated trials at Schering-Plough and international product launches with Novo Nordisk. My goal is to capitalize on my experience across a range of medical affairs disciplines and utilize my strong communication and strategic management skills to bring value to a dynamic organization and influence patient outcomes.